Interatrial Septum: Definition, Clinical Significance, and Overview

Posted on February 28, 2026 | by drheartcare

Interatrial Septum Introduction (What it is)

The Interatrial Septum is the wall of tissue that separates the right atrium from the left atrium.
It is a core structure in cardiac anatomy and is closely tied to congenital heart disease and intracardiac blood flow patterns.
Clinicians commonly assess it with echocardiography and cardiac imaging to evaluate shunts, embolic risk, and atrial structure.
It is also a key landmark for procedures that require access to the left atrium.

Clinical role and significance

The Interatrial Septum matters because it defines the normal separation of systemic venous blood (right atrium) from oxygenated pulmonary venous blood (left atrium). When this partition is incomplete or functionally open—such as with an atrial septal defect (ASD) or patent foramen ovale (PFO)—blood can shunt between atria, altering cardiac hemodynamics and, in some settings, contributing to right-sided volume overload, pulmonary hypertension physiology, or paradoxical embolism.

Beyond congenital defects, the septum is clinically important as an anatomic “gateway” to the left atrium. Many electrophysiology and structural heart procedures (for example, catheter ablation for atrial fibrillation or transcatheter mitral interventions in selected centers) rely on transseptal puncture or passage across the Interatrial Septum. The septum’s thickness, mobility, and relationship to adjacent structures influence procedural planning and complication risk.

The Interatrial Septum also carries diagnostic value in stroke evaluation, especially when clinicians consider right-to-left shunting, and it may be involved in rarer findings such as atrial septal aneurysm, lipomatous hypertrophy, thrombus-in-transit, or tumors that appear to arise near the septal region. In short, it is simultaneously a foundational anatomic boundary, a potential site of congenital and acquired pathology, and a procedural landmark.

Indications / use cases

Common clinical contexts where the Interatrial Septum is discussed or assessed include:

Evaluation of suspected ASD or PFO on transthoracic echocardiography (TTE) or transesophageal echocardiography (TEE)
Assessment of intracardiac shunt magnitude and direction (left-to-right vs right-to-left), often with color Doppler and agitated saline (“bubble study”)
Work-up of cryptogenic stroke or transient ischemic attack (TIA) where paradoxical embolism is a consideration
Investigation of unexplained right atrial/right ventricular dilation or signs of right-sided volume overload
Pre-procedural planning for transseptal access (e.g., atrial fibrillation ablation, left atrial appendage occlusion in selected patients, certain transcatheter mitral procedures)
Characterization of septal masses or abnormal thickening (e.g., lipomatous hypertrophy) seen on echocardiography, cardiac magnetic resonance (CMR), or computed tomography (CT)
Evaluation of pulmonary hypertension physiology when shunting or elevated right-sided pressures may change shunt direction

Contraindications / limitations

The Interatrial Septum itself is an anatomic structure rather than a therapy, so classic “contraindications” do not apply. The closest relevant limitations are situations where assessment is constrained or where septal anatomy makes certain approaches less suitable:

Imaging limitations: Suboptimal acoustic windows on TTE (e.g., due to body habitus or lung disease) may limit septal visualization and shunt detection.
TEE constraints: TEE may be limited in patients who cannot tolerate esophageal instrumentation or sedation; appropriateness varies by clinician and case.
Transseptal access challenges: Unusual septal anatomy (thickened septum, aneurysmal septum, prior device closure, complex congenital repairs) can make transseptal puncture more technically complex and may favor alternative procedural strategies.
Hemodynamic confounding: Shunt direction and size can vary with loading conditions and right-sided pressures, so a single study may not capture physiology under different states.
Diagnostic specificity: A positive bubble study suggests shunting but does not always distinguish intracardiac (PFO/ASD) from intrapulmonary shunt without careful technique and interpretation.

How it works (Mechanism / physiology)

The Interatrial Septum functions as a partition that supports pressure and flow separation between the right and left atria. In typical adult physiology, left atrial pressure is slightly higher than right atrial pressure, which helps keep the septal flap closed when a PFO is present.

Relevant anatomy and neighboring structures

Key anatomic concepts include:

Fossa ovalis: The thin, central portion of the Interatrial Septum that represents the postnatal remnant of the fetal foramen ovale.
Septum primum and septum secundum: Embryologic components that form the region of the foramen ovale; incomplete fusion can leave a PFO.
Atrioventricular valves and inflow: The septum sits between tricuspid inflow (right) and mitral inflow (left), influencing the interpretation of Doppler and chamber enlargement.
Conduction system context: While atrial conduction pathways are distributed broadly, septal tissue can be relevant during electrophysiology mapping and ablation strategies.
Adjacent vascular landmarks: The superior vena cava and inferior vena cava enter the right atrium near the septum; pulmonary veins enter the left atrium. Their relationships matter when localizing sinus venosus defects and planning interventions.

Physiologic principle: shunting and hemodynamics

When a defect is present, flow across the Interatrial Septum follows pressure gradients and compliance:

Left-to-right shunt (common in ASD): Typically increases right atrial and right ventricular volume load and can increase pulmonary blood flow over time.
Right-to-left shunt (possible in PFO/ASD): Can occur transiently (e.g., with Valsalva maneuver) or persistently when right-sided pressures are elevated, allowing venous emboli to enter systemic circulation (paradoxical embolism).

“Onset/duration” is not applicable as it would be for a drug; instead, septal physiology changes with development (fetal to postnatal closure) and can vary dynamically with respiration, posture, and hemodynamics.

Interatrial Septum Procedure or application overview

Because the Interatrial Septum is not itself a procedure, “application” most often means how it is assessed and how it is used as a landmark for interventions. A typical high-level workflow looks like this:

Evaluation/exam – History and exam clues (e.g., unexplained dyspnea, right-sided dilation on prior imaging, stroke of unclear source, murmur patterns) prompt targeted assessment.
Diagnostics – TTE as an initial study to assess chamber size, Doppler flow, and suspected septal defects. – Agitated saline contrast (bubble study) to detect right-to-left shunt under resting conditions and with provocative maneuvers. – TEE for higher-resolution evaluation of PFO anatomy, ASD rims, atrial septal aneurysm, and device planning when needed. – CMR or cardiac CT in selected cases to quantify shunt fraction, define complex anatomy, or assess associated congenital structures.
Preparation (when intervention is considered) – Multi-disciplinary planning (cardiology, interventional cardiology, electrophysiology, cardiothoracic surgery) depending on the scenario. – Review of septal morphology, defect type, surrounding rims, and adjacent structures.
Intervention/testing (when applicable) – Percutaneous device closure for selected secundum ASDs or PFOs, depending on anatomy and clinical context. – Transseptal puncture to access the left atrium for electrophysiology ablation or structural procedures; imaging guidance may include fluoroscopy, TEE, or intracardiac echocardiography (ICE).
Immediate checks – Confirmation of device position (if placed), residual shunt assessment, and evaluation for pericardial effusion in procedural settings.
Follow-up/monitoring – Repeat imaging and clinical follow-up intervals vary by clinician and case, and by device, material, and institution when devices are used.

Types / variations

Important variations relate to normal anatomy, congenital openings/defects, and acquired or iatrogenic changes:

Normal adult septum
Thin fossa ovalis with thicker muscular rims (limbus).
Variable mobility with respiration and loading conditions.
Patent foramen ovale (PFO)
A flap-like potential space from incomplete fusion rather than a true “hole.”
May be associated with atrial septal aneurysm in some patients.
Atrial septal defects (ASDs)
Secundum ASD: Located at/near the fossa ovalis; often the most amenable to device closure when anatomy is suitable.
Primum ASD: Part of atrioventricular septal defect spectrum; associated with atrioventricular valve abnormalities and typically managed surgically in many contexts.
Sinus venosus ASD: Near superior or inferior vena cava; often associated with anomalous pulmonary venous return; commonly requires surgical repair.
Coronary sinus defect (unroofed coronary sinus): Less common; anatomy-driven management.
Atrial septal aneurysm
Excessive mobility/bowing of the septal tissue; clinical significance is context-dependent.
Lipomatous hypertrophy of the interatrial septum
Benign fatty thickening, often sparing the fossa ovalis; may be incidental.
Iatrogenic atrial septal defect
Can occur after transseptal puncture; persistence varies by technique and patient factors.
Masses and thrombus
Rarely, tumors or thrombi may involve or appear adjacent to the septum; differentiation relies on imaging modality and clinical context.

Advantages and limitations

Advantages:

Helps explain core cardiopulmonary physiology (pressure separation and shunt dynamics) in an exam-relevant way
Provides a high-yield framework for congenital heart disease classification (PFO vs ASD subtypes)
Serves as a central imaging target on echocardiography (TTE/TEE) and cross-sectional imaging (CMR/CT)
Guides procedural planning for transseptal access to the left atrium (electrophysiology and structural heart)
Links anatomy to clinical syndromes such as right-sided volume overload and paradoxical embolism
Allows noninvasive shunt screening with Doppler and bubble study in appropriate settings

Limitations:

Septal findings can be dynamic; shunt detection may depend on maneuvers, hydration status, and right-sided pressures
TTE may miss small PFOs or underestimate complex defects when image quality is limited
Bubble study interpretation requires technique awareness; timing of bubbles and provocation affect sensitivity and specificity
Not all septal variants have clear clinical implications; significance often depends on the patient’s broader risk profile
Some defects (e.g., sinus venosus, primum) may be underrecognized without advanced imaging or expert review
When interventions are considered, suitability depends on detailed anatomy; results vary by device, material, and institution

Follow-up, monitoring, and outcomes

Monitoring and outcomes depend on the underlying septal finding and the patient’s physiology rather than the Interatrial Septum alone. Practical factors that commonly shape follow-up include:

Defect type and size: Larger ASDs and certain subtypes more often correlate with chamber enlargement and longer-term hemodynamic impact.
Shunt direction and right-sided pressures: Development of pulmonary hypertension physiology can change shunt behavior and clinical priorities.
Comorbidities: Atrial fibrillation, heart failure, chronic lung disease, and hypercoagulable states can influence symptoms, embolic risk assessment, and procedural candidacy.
Imaging endpoints: Clinicians often track right atrial/right ventricular size, estimated pulmonary pressures, and residual shunt when relevant.
After device closure (when performed): Follow-up typically focuses on device position, residual flow, arrhythmias, and endocarditis prevention considerations per institutional practice; exact intervals vary by clinician and case.
After transseptal procedures: Monitoring may include evaluation for pericardial effusion immediately post-procedure and assessment for persistent iatrogenic shunt if clinically relevant.

“Outcomes” should be interpreted broadly: symptom burden, exercise tolerance, chamber remodeling, arrhythmia occurrence, and cerebrovascular events are all context-dependent, and no single septal measurement predicts them in isolation.

Alternatives / comparisons

Because the Interatrial Septum is an anatomic structure, “alternatives” generally refer to alternative diagnostic modalities or management pathways for septal defects or septum-related clinical questions:

Observation and monitoring vs closure
Small defects or incidental variants may be followed with periodic reassessment, especially when there is no clear hemodynamic consequence.
Closure (percutaneous device or surgery) may be considered for selected ASDs or PFOs depending on symptoms, chamber effects, stroke evaluation context, and anatomy; appropriateness varies by clinician and case.
TTE vs TEE vs intracardiac echocardiography (ICE)
TTE is noninvasive and often first-line but may be limited in resolution.
TEE provides higher detail for PFO/ASD anatomy and device planning but is semi-invasive and may require sedation.
ICE is often used during catheter-based procedures to guide transseptal access and device work, with trade-offs in invasiveness and resource use.
CMR vs CT for anatomy and quantification
CMR can quantify shunt fraction and ventricular volumes without ionizing radiation, but availability and patient suitability vary.
CT offers high spatial resolution for anatomy and pulmonary venous connections but uses ionizing radiation and contrast considerations.
Surgery vs transcatheter approaches
Many secundum ASDs are considered for device closure when rims and size are suitable.
Primum and sinus venosus defects more often require surgical repair due to associated anatomy, though strategies depend on institutional expertise.

Interatrial Septum Common questions (FAQ)

Q: Is an Interatrial Septum problem the same as a heart murmur?
A murmur is a sound from turbulent blood flow and is not a diagnosis by itself. Some ASDs can be associated with murmurs due to increased flow across right-sided valves, but many PFOs do not cause an audible murmur. The relationship depends on defect type, shunt size, and hemodynamics.

Q: Does evaluating the Interatrial Septum hurt?
Standard transthoracic echocardiography (TTE) is noninvasive and typically not painful. Transesophageal echocardiography (TEE) may cause throat discomfort and usually involves sedation or anesthesia per local practice. Procedural discomfort varies by clinician and case.

Q: What is a “bubble study,” and what does it show?
A bubble study uses agitated saline contrast during echocardiography to detect right-to-left shunting. If microbubbles appear in the left atrium shortly after appearing in the right atrium, an intracardiac shunt such as a PFO may be present. Interpretation depends on timing, technique, and provocative maneuvers.

Q: If someone has a PFO, does it always need to be closed?
Not necessarily. Many PFOs are incidental findings and never cause symptoms. Decisions about closure are individualized and depend on the clinical scenario (such as stroke evaluation), competing risk factors, and septal anatomy; appropriateness varies by clinician and case.

Q: How long do results “last” after device closure of an ASD or PFO?
A closure device is intended to be a permanent implant, with tissue growth over time helping to seal the defect. Long-term results depend on anatomy, residual shunt (if any), and patient factors such as arrhythmia risk. Follow-up strategies vary by device, material, and institution.

Q: Is closing a septal defect considered safe?
Percutaneous and surgical approaches are commonly performed, but all interventions carry risks (for example, bleeding, arrhythmia, device-related complications, or procedural injury). The risk profile depends on defect type, patient comorbidities, and operator/institutional experience. Safety is best discussed in general terms and assessed case-by-case.

Q: What kind of anesthesia is used for septum-related procedures?
Diagnostic TTE uses no anesthesia. TEE often uses moderate sedation or anesthesia depending on local practice. Transcatheter closure or transseptal procedures may use conscious sedation or general anesthesia; choices vary by clinician and case.

Q: Are there activity restrictions after an Interatrial Septum procedure?
After diagnostic imaging alone, restrictions are usually minimal. After catheter-based procedures (e.g., device closure or ablation with transseptal access), temporary restrictions may be recommended based on vascular access site care and recovery; details vary by clinician and case. For surgical repair, recovery and restrictions are generally more extensive and individualized.

Q: How often is follow-up imaging needed when a septal defect is found?
Follow-up intervals depend on the defect type, size, symptoms, right heart size, and whether an intervention was performed. Some patients need periodic echocardiography to monitor right-sided chamber size and pulmonary pressures, while others may require less frequent reassessment. Exact timing varies by clinician and case.

Q: What does it mean if the Interatrial Septum is described as “aneurysmal”?
An atrial septal aneurysm refers to unusually mobile septal tissue, often involving the fossa ovalis region. It can be an incidental finding, but it is sometimes discussed alongside PFO in embolic risk evaluation. Clinical relevance depends on accompanying findings and the patient’s overall risk context.